Skip to main content
. 2021 Nov 24;191(2):451–458. doi: 10.1007/s10549-021-06453-8

Fig. 1.

Fig. 1

Flowchart depicting study design for analysis of ILC patients; ILC invasive lobular carcinoma, IDC invasive ductal carcinoma, and RS recurrence score